TAZOCIN 4.5 GM – I V – 1 VIAL

* TAZOCIN 4g/0.500 g, lyophilized powder for intravenous infusion. For INTRAVENOUS USE only (Contains EDTA).
* COMPOSITION: One vial contains:
& & Piperacillin sodium (equiv. to 4 g piperacillin) 4170 mg;
& & Tazobactam sodium (equiv. to 500 mg tazobactam) 536.6 mg.
* Excipients:
& & Citric Acid Monohydrate – Disodium Edetate Monohydrate (Ph. Eur. compliant).
* WARNINGS:
& & – For intravenous use only.
& & – Do not administer intramuscularly.
* STORAGE METHODS:
& & – Lyophilized powder: The vials containing the sterile Tazocin lyophilized powder may be stored at room temperature
& & (Do not store above 25 degrees C) until the expiration date printed on the box.
& & – Solutions: The vials containing the reconstituted solutions for intravenous use are stable for 24 hours at room
& & temperature and up to 48 hours in the refrigerator (2-8 degrees C). Unused solutions must be discarded.
* Dispose of in an environmentally correct manner after use.
* The expiration date indicated refers to the product in the intact package, properly stored.
* Manufactured by: Wyeth Lederle S.p.A. – Catania (Italy). Imported by: Wyeth Egypt.
& & Marketing Authorization Holder: Wyeth Lederle S.p.A. – Catania (Italy).